BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 12363457)

  • 1. Tamoxifen ("Nolvadex"): a review.
    Clemons M; Danson S; Howell A
    Cancer Treat Rev; 2002 Aug; 28(4):165-80. PubMed ID: 12363457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen resistant and refractory breast cancer: the value of aromatase inhibitors.
    Goss PE; Strasser K
    Drugs; 2002; 62(6):957-66. PubMed ID: 11929341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aromatase inhibitors for breast cancer: pharmacoeconomic considerations.
    Higa GM
    Expert Opin Pharmacother; 2001 Jun; 2(6):987-95. PubMed ID: 11585014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tamoxifen and aromatase inhibitors in the treatment of breast cancer in menopausal women: pharmacological and clinical aspects].
    de Cremoux P; Diéras V; Poupon MF; Magdelénat H; Sigal-Zafrani B; Fourquet A; Pierga JY
    Bull Cancer; 2004 Dec; 91(12):917-27. PubMed ID: 15634633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological rationale for endocrine therapy in breast cancer.
    Miller WR
    Best Pract Res Clin Endocrinol Metab; 2004 Mar; 18(1):1-32. PubMed ID: 14687595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shifting paradigms in hormonal therapy for breast cancer.
    Grana G
    Cancer Biol Ther; 2004 Sep; 3(9):797-805. PubMed ID: 15467423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of aromatase inhibitors in postmenopausal women with advanced breast cancer.
    Roseman BJ; Buzdar AU; Singletary SE
    J Surg Oncol; 1997 Nov; 66(3):215-20. PubMed ID: 9369969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective oestrogen receptor modulators/new antioestrogens: a clinical perspective.
    Robertson JF
    Cancer Treat Rev; 2004 Dec; 30(8):695-706. PubMed ID: 15541579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New developments in the hormonal treatment of breast cancer in postmenopausal women].
    Trunet P; Marty M
    Bull Cancer; 1999 Oct; 86(10):815-20. PubMed ID: 10572232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selecting adjuvant endocrine therapy for breast cancer.
    Eneman JD; Wood ME; Muss HB
    Oncology (Williston Park); 2004 Dec; 18(14):1733-44, discussion 1744-5, 1748, 1751-4. PubMed ID: 15700624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy of tamoxifen.
    Robert NJ
    Oncology (Williston Park); 1997 Feb; 11(2 Suppl 1):15-20. PubMed ID: 9065922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the treatment of endocrine responsive metastatic breast cancer in postmenopausal women.
    Cardoso F; Bischoff J; Brain E; Zotano ÁG; Lück HJ; Tjan-Heijnen VC; Tanner M; Aapro M
    Cancer Treat Rev; 2013 Aug; 39(5):457-65. PubMed ID: 22840697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine therapy for early breast cancer.
    Hussain SA; Williams S; Stevens A; Rea DW
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):877-88. PubMed ID: 15485321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aromatase inhibitors versus tamoxifen for management of postmenopausal breast cancer in the advanced disease and neoadjuvant settings.
    Ingle JN; Suman VJ
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):313-9. PubMed ID: 14623527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the current use of hormonals as therapy in advanced breast cancer.
    Vogel CL
    Anticancer Drugs; 2003 Apr; 14(4):265-73. PubMed ID: 12679730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine treatment options for advanced breast cancer--the role of fulvestrant.
    Robertson JF; Come SE; Jones SE; Beex L; Kaufmann M; Makris A; Nortier JW; Possinger K; Rutqvist LE
    Eur J Cancer; 2005 Feb; 41(3):346-56. PubMed ID: 15691633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal therapy of breast cancer.
    Locker GY
    Cancer Treat Rev; 1998 Jun; 24(3):221-40. PubMed ID: 9767736
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical review: Effect of endocrine therapies on bone in breast cancer patients.
    Santen RJ
    J Clin Endocrinol Metab; 2011 Feb; 96(2):308-19. PubMed ID: 21147884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic potential of aromatase inhibitors.
    Miller WR; Jackson J
    Expert Opin Investig Drugs; 2003 Mar; 12(3):337-51. PubMed ID: 12605559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in endocrine therapy of breast cancer.
    Howell A; Dowsett M
    BMJ; 1997 Oct; 315(7112):863-6. PubMed ID: 9353509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.